Browsing: Wellness Tips

Abuja played host to the launch of Becoming Light, the debut book by wellness advocate and author, Cherub E. O., bringing together family, friends, health professionals, business leaders, and wellness advocates

Novo Nordisk ($NVO) filed a lawsuit against Eli Lilly ($LLY), alleging Lilly’s advertising for Zepbound and Mounjaro relies on outdated clinical comparisons that understate the performance of Novo’s latest higher-dose Wegovy and Ozempic treatments. Novo is seeking to halt the advertising, require corrective marketing, and recover damages as the companies compete in the growing obesity…

Morning Brief host Julie Hyman discusses the details with Yahoo Finance Breaking Business News Reporter Jake Conley and Payne Capital Management president Ryan Payne

The battle of big pharma rages on as Novo Nordisk takes a shot at rival Eli Lilly in a new misleading advertising lawsuit

ST. LOUIS, July 21, 2026 /PRNewswire/ — As use of emerging obesity medications (EOMs) continues to rise, a new perspective published in Advances in Nutrition suggests these medications may create an unprecedented opportunity to help patients adopt healthier, more plant-forward dietary patterns. EOMs such as glucagon-like peptide-1 (GLP-1) receptor agonists quiet “food noise”—the persistent, intrusive thoughts about…

The maker of Wegovy and Ozempic, Novo Nordisk, has launched legal action accusing its arch rival Eli Lilly of false advertising in suggesting its weight-loss drugs perform better

Novo Nordisk on Tuesday filed a lawsuit against Eli Lilly, alleging that its advertising campaigns for its blockbuster obesity and diabetes drugs are designed to mislead consumers about their superior efficacy relative to the Danish drugmaker’s rival injections. 

Novo Nordisk filed a lawsuit against Eli Lilly on Tuesday, alleging that advertising campaigns for Lilly’s obesity drug Zepbound and diabetes drug Mounjaro mislead consumers by using outdated clinical data to suggest those treatments are more effective than Novo’s rival injections

Novo Nordisk sued Eli Lilly on July 21 over what Novo said is false and misleading advertising comparing the effectiveness of the drug companies’ respective injectable weight-loss medicines

Noom, the leading behaviour change company, launched Lose for Keeps, a new integrated brand campaign featuring Rebel Wilson in her second year as the company’s Chief Wellness Ambassador. The campaign tackles a question at the centre of the GLP-1 era: how do you make weight loss last?